Bioassays, integral to pharmacology, assess drug effects on living organisms. In vitro assays use isolated cells, aiding early drug screening, mechanism understanding, and target validation. In vivo assays, though resource-intensive, offer comprehensive insights, vital in later stages of drug development. Bioassays determine drug potency, ensuring batch consistency and supporting safety assessment. Advancements like high-throughput screening, omics technologies, and organ-on-a-chip enhance efficiency. Bioassays play pivotal roles in therapeutic areas like oncology, neuropharmacology, and infectious diseases. Regulatory considerations emphasize validation, standardization, and bioassay data in submissions. Future perspectives include AI integration and biomarker discovery, promising more effective and personalized pharmacological interventions.
https://www.pharmafocuseurope.com/articles/exploring-the-benefits-of-bioassay-in-pharmacology